Anthem Biosciences IPO: Strong Listing Day Performance Analysis

Anthem Biosciences IPO: Strong Listing Day Performance Analysis

Anthem Biosciences made a powerful debut on July 21, 2025, with shares opening at ₹723 on NSE/BSE—around 26.85% above the IPO price of ₹570. By day’s close, it touched ₹730–₹732, yielding a 28.3% premium, translating into a valuation of approximately ₹41,000 crore ($4.75 billion) Robust trading ensued: 4.10 crore shares changed hands, totalling a turnover of ₹2,290 crore, with a VWAP…

Anthem Biosciences IPO: A Comprehensive Analysis for Investors

Anthem Biosciences IPO: A Comprehensive Analysis for Investors

`The Anthem Biosciences IPO offers investors a unique opportunity to tap into India’s fast-growing CRDMO (Contract Research, Development, and Manufacturing Organization) sector. With a total issue size of ₹3,395 crore and a price band of ₹540–570 per share, the Anthem Biosciences IPO provides direct exposure to a leading innovation-driven pharmaceutical service provider. This analysis explores…